Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
McKesson
Moodys
AstraZeneca
Dow

Last Updated: August 17, 2022

Xgen Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for XGEN PHARMS, and what generic and branded alternatives to XGEN PHARMS drugs are available?

XGEN PHARMS has twenty approved drugs.



Summary for Xgen Pharms
US Patents:0
Tradenames:19
Ingredients:19
NDAs:20

Drugs and US Patents for Xgen Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xgen Pharms LIOTHYRONINE SODIUM liothyronine sodium INJECTABLE;INJECTION 076923-001 Aug 17, 2005 AP RX No No See Plans and Pricing See Plans and Pricing
Xgen Pharms NYSTATIN nystatin POWDER;TOPICAL 065175-001 Dec 17, 2004 AT RX No No See Plans and Pricing See Plans and Pricing
Xgen Pharms DACTINOMYCIN dactinomycin INJECTABLE;INJECTION 203999-001 May 20, 2019 AP RX No No See Plans and Pricing See Plans and Pricing
Xgen Pharms NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 065220-001 Jul 28, 2006 AA RX No No See Plans and Pricing See Plans and Pricing
Xgen Pharms NEOMYCIN AND POLYMYXIN B SULFATE neomycin sulfate; polymyxin b sulfate SOLUTION;IRRIGATION 065106-001 Jan 31, 2006 AT RX No No See Plans and Pricing See Plans and Pricing
Xgen Pharms ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 040784-001 Dec 10, 2008 AP RX No Yes See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Medtronic
Express Scripts
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.